Silber Beata Y, Croft Rodney J, Papafotiou Katherine, Stough Con
Drugs and Driving Research Unit, Brain Sciences Institute, Swinburne University of Technology, 400 Burwood Rd, Hawthorn, Victoria 3122, Australia.
Psychopharmacology (Berl). 2006 Aug;187(2):154-69. doi: 10.1007/s00213-006-0410-7. Epub 2006 Jun 8.
It is not clear how the deleterious effects of amphetamines on driving performance are mediated in terms of select cognitive processes.
The current three separate experiments assessed the acute effects of an oral dose of either 0.42-mg/kg d-amphetamine, d,l-methamphetamine and d-methamphetamine on driving-related cognitive functions in a total of 60 healthy non-fatigued adults.
Three separate repeated measures counterbalanced, double-blind, placebo-controlled designs were employed in which 20 volunteers completed two treatment conditions, either d-amphetamine, d,l-methamphetamine or d-methamphetamine and placebo. Performance was assessed on a range of attentional, psychomotor and perceptual speed tasks.
Mean blood concentrations at 120-, 170- and 240-min postdrug administration were 83, 98 and 96 ng/ml, respectively, for d-amphetamine, 90, 95 and 105 ng/ml, respectively, for d,l-methamphetamine and 72, 67 and 59 ng/ml, respectively, for d-methamphetamine. The amphetamines, in general, improved various aspects of attention (Digit Vigilance, Digit Symbol Substitution Test and Movement Estimation Performance) with some evidence to suggest possible enhancement in psychomotor functioning (Tracking ability) and perceptual speed (Inspection Time).
The current series of studies primarily provides evidence of low-level amphetamine-related enhancement of function; however, it also provides evidence of less conservative movement estimation that might contribute to amphetamine-related road fatalities.
苯丙胺对驾驶性能的有害影响是如何通过特定认知过程介导的尚不清楚。
当前的三项独立实验评估了口服0.42毫克/千克剂量的右旋苯丙胺、消旋甲基苯丙胺和右旋甲基苯丙胺对60名健康非疲劳成年人驾驶相关认知功能的急性影响。
采用三项独立的重复测量、平衡、双盲、安慰剂对照设计,其中20名志愿者完成两种治疗条件,即右旋苯丙胺、消旋甲基苯丙胺或右旋甲基苯丙胺与安慰剂。在一系列注意力、心理运动和感知速度任务上评估表现。
给药后120分钟、170分钟和240分钟时,右旋苯丙胺的平均血药浓度分别为83纳克/毫升、98纳克/毫升和96纳克/毫升,消旋甲基苯丙胺分别为90纳克/毫升、95纳克/毫升和105纳克/毫升,右旋甲基苯丙胺分别为72纳克/毫升、67纳克/毫升和59纳克/毫升。一般来说,苯丙胺改善了注意力的各个方面(数字警觉、数字符号替换测试和运动估计表现),有证据表明心理运动功能(跟踪能力)和感知速度(检查时间)可能得到增强。
当前系列研究主要提供了低水平苯丙胺相关功能增强的证据;然而,它也提供了不太保守的运动估计的证据,这可能导致与苯丙胺相关的道路死亡事故。